Diabetes, Obesity and Metabolism

Cover image for Vol. 17 Issue 4

Accepted Articles (Accepted, unedited articles published online and citable. The final edited and typeset version of record will appear in future.)

Edited By: R. Donnelly and A. Garber

Impact Factor: 5.456

ISI Journal Citation Reports © Ranking: 2013: 17/124 (Endocrinology & Metabolism)

Online ISSN: 1463-1326

VIEW

  1. 1 - 14
  1. RESEARCH LETTERS

  2. Original Articles

    1. Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

      Tim Heise, Ulrike Hövelmann, Lise Brøndsted, Charlotte L. Adrian, Leszek Nosek and Hanne Haahr

      Accepted manuscript online: 1 APR 2015 04:48AM EST | DOI: 10.1111/dom.12468

  3. RESEARCH LETTERS

    1. HDAC3 inhibition improves glycemia and insulin secretion in obese diabetic rats

      Morten Lundh, Thomas Galbo, Steen S. Poulsen and Thomas Mandrup-Poulsen

      Accepted manuscript online: 1 APR 2015 04:47AM EST | DOI: 10.1111/dom.12470

  4. Original Articles

    1. Treatment escalation options for patients with type 2 diabetes after failure of exenatide BID or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) Study

      G. Schernthaner, J. Rosas-Guzmán, F. Dotta, B. Guerci, R. Simó, A. Festa, J. Kiljański, M. Zhou and B. Gallwitz

      Accepted manuscript online: 1 APR 2015 04:46AM EST | DOI: 10.1111/dom.12471

    2. The safety and effectiveness of non-insulin glucose lowering agents in the treatment of people with Type 2 Diabetes who observe Ramadan: A systematic review and meta-analysis

      Laura J. Gray, Jolyon Dales, Emer M. Brady, Kamlesh Khunti, Wasim Hanif and Melanie J. Davies

      Accepted manuscript online: 16 MAR 2015 02:13AM EST | DOI: 10.1111/dom.12462

    3. Incretin-based medications for type 2 diabetes: an overview of reviews

      John-Michael Gamble, Amy Clarke, Kristina J. Myers, Meghan D. Agnew, Kelly Hatch, Megan M. Snow and Erin M. Davis

      Accepted manuscript online: 16 MAR 2015 02:12AM EST | DOI: 10.1111/dom.12465

    4. Long-term treatment with empagliflozin as add-on to oral anti-diabetes therapy in Japanese patients with type 2 diabetes mellitus

      E. Araki, Y. Tanizawa, Y. Tanaka, A. Taniguchi, K. Koiwai, G. Kim, A. Salsali, H. J. Woerle and U. C. Broedl

      Accepted manuscript online: 16 MAR 2015 02:12AM EST | DOI: 10.1111/dom.12464

    5. Insulin degludec/insulin aspart produces a dose-proportional glucose-lowering effect in subjects with type 1 diabetes mellitus

      T. Heise, L. Nosek, O. Klein, H. Coester, A.L. Svendsen and H. Haahr

      Accepted manuscript online: 16 MAR 2015 02:11AM EST | DOI: 10.1111/dom.12463

    6. Efficacy and tolerability of saxagliptin compared with glimepiride in elderly patients with type 2 diabetes: a randomized, controlled study (GENERATION)

      G. Schernthaner, S. Durán-Garcia, M. Hanefeld, G. Langslet, L. Niskanen, C. J. Östgren, E. Malvolti and E. Hardy

      Accepted manuscript online: 12 MAR 2015 02:27AM EST | DOI: 10.1111/dom.12461

  5. ORIGINAL ARTICLES

    1. Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in type 2 diabetes patients: 4-year data

      Stefano Del Prato, Michael Nauck, Santiago Durán-Garcia, Laura Maffei, Katja Rohwedder, Anett Theuerkauf and Shamik Parikh

      Accepted manuscript online: 4 MAR 2015 05:02AM EST | DOI: 10.1111/dom.12459

    2. Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized Phase III trials

      Robert R. Henry, John B. Buse, Haiyan Wu, Laurence M.A. Durrwell, Roberto Mingrino, Karsten E.A. Jaekel, Bouchra El Azzouzi, Mirjana Andjelkovic and Matthias Herz

      Accepted manuscript online: 25 FEB 2015 03:41AM EST | DOI: 10.1111/dom.12455

  6. Original Paper

    1. Glucose-lowering effect and glycemic variability of insulin glargine, insulin detemir, and insulin lispro protamine in people with type 1 diabetes

      Giuseppe Derosa, Ivano Franzetti, Fabrizio Querci, Davide Romano, Angela D'Angelo and Pamela Maffioli

      Accepted manuscript online: 19 FEB 2015 02:53AM EST | DOI: 10.1111/dom.12454

VIEW

  1. 1 - 14

SEARCH

SEARCH BY CITATION